Wright Medical gets FDA reclassification decision
This article was originally published in Clinica
Executive Summary
Resorbable calcium salt used to fill bony voids or gaps of the extremities, spine and pelvis has been classified by the FDA as a class II, or medium-risk, device subject to special control. The special control is adherence to a new guidance document on the product, the agency said.